Basic Research
Establishment of the culture system of γδ T cells in vitro and the anti-tumor effect
Xie Lei, Chen Wen, Wang Liang, Cheng Min, Hu Shilian, Shen Gan
Published 2018-04-23
Cite as Chin J Oncol, 2018, 40(4): 247-251. DOI: 10.3760/cma.j.issn.0253-3766.2018.04.002
Abstract
ObjectiveTo establish the culture technique for culturing γδ T cells in vitro and evaluate the basic characteristics, security and anti-tumor effect of the cultured γδ T cells.
MethodsPhytohemagglutinin, zoledronic acid, interleukin-2 and interleukin -7 were used to induce the abundant expansion of peripheral blood mononuclear cells in vitro. Flow cytometry assay, in vitro killing assay and mouse model of human lung cancer were also adopted to assess the characteristics and the anti-tumor effect of cultured γδ T cells. Additionally, the contamination of exogenous agents and the acute toxicity of γδ T cells were determined.
ResultsAfter culturing 14-16 days in vitro, the total number of γδ T cells was more than 1.0×10 10. Among these γδ T cells, CD3 + γδ TCR + cells accounted for more than 90%. None of contaminations of bacteria, fungi, mycoplasma and virus were observed. At effect target ratio (E/T ratio) of 50/1, killing efficiency of γδ T cells cultured in vitro to SK-MES-1, Ho8910, A549 and K562 reached more than 65%. In vivo experiments showed that the tumor volume of γδ T-treated mice was (828.99±61.05) mm 3, significantly lower than (1 723.51±84.30) mm3 of the control mice (P<0.05). Meanwhile, no acute toxicity effect was observed in γδ T cells treated mice.
ConclusionThe number, purity and activity of γδT cells cultured in our institute can reach the requirement of clinical application, and the γδT cells also display strong cytotoxic activity against tumor cells such as lung cancer, ovarian cancer and leukemia.
Key words:
Lung neoplasms; Tumor immunotherapy; γδ T cells; Anti-tumor effect
Contributor Information
Xie Lei
Department of Geriatric Medicine, Anhui Province Hospital Affiliated Anhui Medical University, Hefei 230001, China
Chen Wen
Anhui Provincial Key Laboratory of Tumor Immunotherapy and Nutrition Therapy, Anhui Province Hospital Affiliated Anhui Medical University, Hefei 230001, China
Wang Liang
Anhui Provincial Key Laboratory of Tumor Immunotherapy and Nutrition Therapy, Anhui Province Hospital Affiliated Anhui Medical University, Hefei 230001, China
Cheng Min
Anhui Provincial Key Laboratory of Tumor Immunotherapy and Nutrition Therapy, Anhui Province Hospital Affiliated Anhui Medical University, Hefei 230001, China
Hu Shilian
Anhui Provincial Key Laboratory of Tumor Immunotherapy and Nutrition Therapy, Anhui Province Hospital Affiliated Anhui Medical University, Hefei 230001, China
Shen Gan
Department of Geriatric Medicine, Anhui Province Hospital Affiliated Anhui Medical University, Hefei 230001, China